Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Traumatología y Ortopedia | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
ClinicalTrials.gov
"Levels of RANKL and OPG in Gingival Crevicular Fluid of Patients With Post-menopausal Osteoporosis / Osteopenia and Periodontal Disease."
OBSERVATIONAL
Inicio: 1 de may de 2012
ID: NCT02184962
Completado
Fase 2
ClinicalTrials.gov
A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Determine the Efficacy, Safety, and Tolerability of AMG 785 in Adults With a Fresh Unilateral Hip Fracture, Status Post Surgical Fixation
INTERVENTIONAL
Inicio: 20 de jun de 2010
ID: NCT01081678
Completado
ClinicalTrials.gov
Drug Interactions and Hip Fracture Risk in Older Adults
OBSERVATIONAL
Inicio: 16 de ago de 2018
ID: NCT04731597
Completado
Fase 3
ClinicalTrials.gov
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
INTERVENTIONAL
Inicio: 16 de oct de 2001
ID: NCT00172133
Completado
ClinicalTrials.gov
Antiresorptive Effects of a 6-m Treatment Course With Ibandronate Plus Supplementation of Vitamine D and Calcium in Central America
OBSERVATIONAL
Inicio: 1 de ene de 2013
ID: NCT02635997
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Double-Blind, Double Dummy, Parallel Group, Dose Ranging Study of Subcutaneous SR123781A With an Enoxaparin Calibrator Arm in the Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Hip Replacement Surgery
INTERVENTIONAL
Inicio: 1 de may de 2006
ID: NCT00338897
Completado
Fase 3
ClinicalTrials.gov
PEARL: Postmenopausal Evaluation And Risk-Reduction With Lasofoxifene
INTERVENTIONAL
Inicio: 1 de nov de 2001
ID: NCT00141323
Desconocido
ClinicalTrials.gov
Multicenter Validation Study of an Artificial Intelligence Tool for Automatic Classification of Chest X-rays
OBSERVATIONAL
Inicio: 1 de jul de 2021
ID: NCT04991987
Completado
Fase 2
ClinicalTrials.gov
A 24-week Double-blind Treatment and 24-week Follow-up, Randomized, Multicenter, Placebo-controlled, Phase IIa/IIb Study to Evaluate Safety and Efficacy of i.v. Bimagrumab on Total Lean Body Mass and Physical Performance in Patients After Surgical Treatment of Hip Fracture
INTERVENTIONAL
Inicio: 16 de sept de 2014
ID: NCT02152761
Completado
Fase 3
ClinicalTrials.gov
An 18-Month Double-Blind, Placebo-Controlled, Phase III, Trial With a 12-Month Interim Analysis of the Effect of Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal Osteoporosis
INTERVENTIONAL
Inicio: 27 de abr de 2000
ID: NCT00172081
Completado
ClinicalTrials.gov
A New Experimental Model of Acute Muscle Pain in Humans Based on Short-wave Diathermy
INTERVENTIONAL
Inicio: 19 de feb de 2018
ID: NCT03573219
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Active-Controlled, Double-Blind Study Comparing Upadacitinib (ABT-494) to Abatacept in Subjects With Moderately to Severely Active Rheumatoid Arthritis With Inadequate Response or Intolerance to Biologic DMARDs (bDMARDs) on Stable Conventional Synthetic Disease Modifying Anti-Rheumatic Drugs (csDMARDs)
INTERVENTIONAL
Inicio: 9 de may de 2017
ID: NCT03086343
Completado
ClinicalTrials.gov
Observational and Cross-Sectional Cohort Study of the Natural History and Phenotypic Spectrum of Farber Disease
OBSERVATIONAL
Inicio: 22 de nov de 2017
ID: NCT03233841
Anterior
1
...
4
5
6
...
434
Siguiente
Filtros